rosiglitazone has been researched along with stearates in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andres, J; Assmann, A; Biedasek, K; Bobbert, T; Diederich, S; Graham, I; Larson, TR; Mai, K; Pfeiffer, AF; Spranger, J | 1 |
1 other study(ies) available for rosiglitazone and stearates
Article | Year |
---|---|
Rosiglitazone increases fatty acid Δ9-desaturation and decreases elongase activity index in human skeletal muscle in vivo.
Topics: Acetyltransferases; Cell Line; Fatty Acid Elongases; Fatty Acids; Fatty Acids, Unsaturated; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Muscle, Skeletal; PPAR gamma; RNA, Messenger; Rosiglitazone; Stearates; Stearoyl-CoA Desaturase; Sterol Regulatory Element Binding Protein 1; Thiazolidinediones | 2012 |